Accepted for publication 29th March, 1993. in those patients given C preoperatively than in those who received either D or P. The peak increase in mean blood pressure was 39O/o (C) The ideal intravenous induction agent should have a rapid onset and short duration of action while producing ade-CAN J ANAESTH 1993 / 40:7 / pp612-8
L'induction de l'anesth~sie s'accompagne souvent de changements indksirables de la tension art~rielle et de la fr~quence cardiaque. En pr~m~dication, on a d~montrO que la clonidine diminuait ces effets dOfavorables. D'autres agonistes alpha2 ont ~t~ utilisks chez l'animal pour att~nuer les effets cardiostimulateurs de la k~tamine, mais nous ne possOdons que peu de donn~es sur l'utilisation de cette association chez l'humain. Les effets de la clonidine orale en pr~m~dication ~ la posologie de 5 #g " kg -1 sur les changements h~modynamiques provoqu~s par la kOtamine sont ~tudi~s chez 42 patients volontaires. Quatre-vingt dix minutes avant la chirurgie, les patients recoivent au hasard et gl double insu soit de la clonidine (C), du diazepam (D), ou un placebo (P). L'anesth~sie est induite avec une perfusion de k~tamine 1 rag' kg -I" min -t jusqu'h la perte de conscience. La frOquence cardiaque et la tension arMrielle sont mesur~es de far non invasive avant Hnduction, avant Hntubation et jusqu'h sept minutes aprks celle-ci. On ne trouve pas de differences d~mographiques ou de parambtres vitaux initiaux entre les trois groupes. Avec l'administration de la k~tamine, l'augmentation de fr~quence cardique et de tension art~rielle est moindre chez les patients qui ont recu C en pr~m~dication que ceux qui ont re~u D ou P. L'augmentation maximale de tension art~rielle moyenne est de 39% (C) vs 70% (D) et 55% (P) (P < 0,01). Nous concluons que la clonidine orale attOnue les effets hyperdynamiques de Hnduction de l'anesth~sie gt la k~tamine i~.
quate and predictable anaesthesia. It should provide haemodynamic stability and be free of adverse effects. Induction agents such as thiopentone are often accompanied by hypotension followed by hypertension during laryngoscopy. Midazolam has similar effects when used as an induction agent ~ and although high-dose narcotics may provide haemodynamic stability, they may have side effects such as bradycardia, chest wall rigidity, and postoperative respiratory depression. 2 Ketamine, a non-barbiturate anaesthetic induction agent, produces a "dissociative" anaesthetic state characterized by a functional and electrophysiological dissociation between the limbic and thalamoneocortical systems. 3 In addition to its anaesthetic properties, it provides profound analgesia at subanaesthetic doses.4 When used as an induction agent, it does not produce respiratory depression and airway reflexes are maintained. Despite causing some direct myocardial depression at higher doses, haemodynamic stability may be maintained in hypovolaemic patients due to its sympathomimetic actions. 4 Ketamine is highly lipid soluble and has a rapid onset of action. After a bolus injection, its effects are relatively short-lived (10-20 min), with redistribution of the drug being mainly responsible for the rapid decrease in plasma concentrations. Despite many apparently desirable traits, ketamine has not enjoyed widespread use. In part, this may be related to its cardiostimulatory effects in normovolaemic patients, s,6 which may be unacceptable in some circumstances.
Clonidine is an oral antihypertensive agent which is known to reduce central sympathetic outflow via central alphaz adrenergic receptor stimulation. 7 Clonidine has been shown to reduce the anaesthetic requirements of halothane 8,9 and isoflurane, to and to reduce the narcotic requirements for anaesthesia during coronary artery bypass surgery, l 1,12 In addition, clonidine is effective in blunting the tachycardia and hypertension associated with tracheal intubation. 10, 13, 14 The sympatholytic activity and anaesthetic sparing action of clonidine in combination with ketamine, may approach the characteristics of the ideal drug combination for induction. In veterinary practice, ketamine is frequently combined with xylazine (an alpha 2 adrenergic agonist similar to clonidine) to produce a smoother anaesthetic state. ~5-17 There are few data on the interaction of any alpha2 adrenergic agonists and ketamine in humans. ~8
The purpose of this study was to observe the early haemodynamic effects associated with induction of anaesthesia with ketamine in patients premedicated with oral clonidine to see if the usual hyperdynamic responses to induction with ketamine were attenuated by prior administration of clonidine. The doses of ketamine required for induction of anaesthesia in patients premedicated with clonidine, placebo or diazepam were compared to determine if there was any reduction in ketamine dose requirements in those patients receiving clonidine.
Methods
After approval by the Human Ethics Committee of the University of Manitoba and informed consent, 42 ASA 1 or 2 patients under 45 yr of age, undergoing elective general or orthopaedic surgery, were recruited. Patients with severe cardio-respiratory, neurological or psychiatric disorders were excluded. Each patient was administered iv fluids (1.5 -2.0 ml-kg -I) while fasting and was randomly assigned to receive either diazepam 0.15 mg. kg -1 (D), clonidine 5 lag" kg -I (C), or placebo (P) orally, 90 min before induction of anaesthesia. Identically appearing capsules containing specific amounts of one of the premedications were prepared by the pharmacy to ensure blinding of patients and investigators to the study drug.
Upon arrival in the operating room, each patient was prepared and monitored in the usual manner. Phasic blood pressure was measured by a noninvasive finger servo-plethysmomanometer device (Fin-a-Pres, Ohmeda). Systolic, diastolic and mean blood pressures and heart rate were recorded during the induction sequence. The sequence consisted of preoxygenation with 100% oxygen by face mask for three minutes, iv d-tubocurarine 0.05 mg-kg -t, and an infusion of ketamine at a rate of 1.0 mg. kg -I. min -l until loss of consciousness. The total dose of ketamine required to induce anaesthesia was recorded. Succinylcholine, 1.5 mg. kg -1, was administered to facilitate tracheal intubation and was followed by ventilation with 70% nitrous oxide and oxygen. A volatile agent was added, at the discretion of the attending anaesthetist, if inadequate anesthesia was evident or for control of hypertension.
Phasic blood pressure and heart rate were measured at nine intervals perioperatively: on the ward prior to receiving the preoperative medication (PREOP), at seven measurement intervals (T0-T6) around induction, and in the recovery room (PARR). Time periods To and Tj represent values on arrival in the operating room (approximately 90 min after receiving the study drug) and before starting the ketamine infusion, respectively. Intervals T2-T 6 represent time periods one minute post-induction, one minute post-intubation, and three, five, and seven minutes post-intubation, respectively. The remainder of the anaesthetic was conducted according to the discretion of the attending anaesthetist. All patients were interviewed in the recovery room by one of the investigators and any adverse psychological reactions were recorded and treated as required. Psychological phenomena were categorized as described by Ramsubramanian et at,* according to the presence or absence of perceptive disorders (dreams, hallucinations, delirium, or confusion) and affective disorders (depression, anxiety, fear). The study groups (C, P, and D) were compared using analysis of variance for repeated measures to detect differences within and between groups for changes in heart rate and blood pressure. Duration of anaesthesia, ketamine dose and demographic variables were compared using Tukey's Studentized Range test. The incidence of psychological side effects, patient acceptance of the anaesthetic experience, and the incidence of requirement of isoflurane supplementation were analyzed by Chi-square. A P-value of <0.05 was considered significant and was adjusted to P < 0.01 (Bonferroni's correction) in the case of multiple comparisons.
Results
The study groups, each consisting of 14 patients, were not different with respect to demographic variables (Table  I) . Heart rate (HR) and systolic (SBP), diastolic (DBP), and mean (MBP) blood pressure changes for the measurement intervals are shown in Table II (all results mean • SD). Before receiving any study drug (PREOP) there were no differences in any of the measured variables among the groups and these were utilized as a baseline with which the other interval data (T0-T 6 and PARR) were compared. Clonidine-treated patients had lower heart rates (P < 0.01) than patients receiving placebo at all subsequent intervals until PARR and their heart rates were lower than those of the diazepam group at T2, T3, and T6 ( Figure I ). Group C patients tended to arrive in the operating room (To) with a heart rate below baseline; however, this did not reach statistical significance when corrected for multiple comparisons (58 + 11 vs 69 • 7, P = 0.019). Heart rate changes associated with induction occurred later and were of lesser magnitude in Group C than in Groups D and P. Clonidine n = 14 pts. in each group. Bonferroni's correction applied for multiple comparisons, ap < 0.01 C vs D and P; bp < 0.01 C vs P only; cP < 0.01 C vs D only; dp < 0.01 D vs P only. HR = heart rate, SBP = systolic blood pressure, DBP = diastolic blood pressure, MBP = mean blood pressure, PREOP = on the ward, prior to receiving premedication; T O = upon arrival in the OR, T I = prior to starting induction sequence, T 2 = 1 min post-induction, T 3 --1 min postintubation, 1"4 = 3 min post-intubation, T s = 5 min post-intubation, T 6 = 7 min post-intubation, PARR = discharge from post-anaesthesia recovery room.
was more effective than either diazepam or placebo (P < 0.01) in attenuating the increase in mean blood pres- Values are means + SD. * P < 0.05, Cvs P. sure (Figure 2 ) during the preinduction period (T0_l) and that associated with induction and intubation (T2_6). The patterns with systolic and diastolic blood pressures were similar (Table II) . The average peak M B P in the clonidine-treated group was 123 + 23, an increase of 35 m m H g (-I-39%) over baseline. Heart rate increased to an average peak of 83 -I-18 b p m which was 14 b p m (20%) above baseline. Figure 3 is a histogram of the frequency of the requirement for intervention with a volatile anaesthetic. No patient required isoflurane until T4, three minutes after intubation and there were no differences a m o n g the three groups. The average ketamine dose requirements for each group were calculated (Table III) . Although the average total ketamine doses were not different a m o n g the groups, when corrected for weight ( m g -kg-]), Group C patients required less ketamine than Group P (1.95 + 0.25 vs 2.39 -t-0.39, P < 0.05). There was no difference between G r o u p C and Group D. Figure 4 is a histogram showing the n u m b e r of patients in each group exhibiting specific psychological phenomena in the recovery room. There were no differences for frequencies of these side effects detected among the groups. Most of the psychological side effects were mild and did not require treatment; however, there were three patients (one per group) who required iv midazolam in the recovery room because of agitation ascribed to hallucinations. The duration of anaesthesia (induction until tracheal extubation) was 116 _ 46, 125 _ 40 and 102 + 39 min for Groups C, D and P, respectively (NS).
All patients were interviewed on the day after anaesthesia and were questioned again about psychological disturbances while in the recovery room or after. Patients were also asked if they would have the same anaesthetic again if given a choice. Of patients who had received clonidine, 12/14 would have the same anaesthetic again, compared with 11/14 who had received diazepam and 7/14 for placebo (NS).
Discussion
Clonidine attenuates the rise in heart rate and blood pressure associated with induction of anaesthesia using iv ketamine. It does not, however, eliminate the cardiosfimulatory effects which agrees with a recent study by Munro et al. ~8 Oral clonidine premedication may be useful to attenuate the cardiostimulatory effects of ketamine in healthy patients but cannot be relied upon to protect against unwanted increases in heart rate and blood pressure in predisposed patients. Many patients required isoflurane supplementation in response to movement and to control undesirable haemodynamic changes. The frequency of requirement for isoflurane supplementation increased with time. This may have been due to decreasing depth of anaesthesia, reflecting the relatively short duration of action of a single dose of ketamine. 4 Clonidine has been shown to reduce the MAC of volatile anaesthetics 8-~0 and decrease narcotic requirements during coronary artery bypass surgery. ~1,~2 Although the patients who received clonidine required less ketamine to induce anaesthesia than those who received diazepam or placebo, we did not specifically examine the MAC requirements following induction of anaesthesia.
The mechanism of clonidine's attenuation of the sympathomimetic effects of ketamine can only be speculated on from this study. The mechanism of the ketamineinduced tachycardia and hypertension is likely multifactorial. ~9 At high doses, ketamine has a direct myocardial depressing effect. This is counteracted in the intact organism by a central sympathetic stimulatory effect which increases circulating catecholamine concentrations. This sympathetic discharge may result from central inhibition of catecholamine reuptake. Inhibition of reuptake of circulating catecholamines also contributes to the increase of plasma concentrations. 20 It is possible that the partial attenuation of the hypertension and tachycardia by clonidine is a result of a functional antagonism of ketamine's centrally mediated sympathetic discharge by a presynaptic alpha2 adrenergically mediated inhibition of catecholamine release or by a postsynaptic alpha2 adrenergically mediated depression of the vasomotor centres in the brain. The effectiveness of either mechanism would be incomplete, as the peripheral action of ketamine to inhibit catecholamine reuptake would still be operative. This may explain why clonidine was unable to eliminate completely the cardiostimulatory effects of ketamine.
It is unlikely that differences in doses of ketamine among the groups had any effect on the magnitude of the haemodynamic changes observed as there appears to be little variation in the peak hypertensive response achieved using ketamine with doses greater than 1 mg-kg-~. 2j The possibility of a shortened duration of hypertension and tachycardia in those patients who received clonidine, secondary to a decreased ketamine dose, cannot be excluded. It is worth noting the haemodynamic state of the patient before induction of anaesthesia (To, T 0. The clonidine-treated patients arrived in the OR drowsy but alert. More importantly, the MBP was unchanged from baseline, whereas patients in the other groups had a marked elevation of MBP (Table II) . This suggests that clonidine was a more effective sedative than diazepam and more effectively blocked the tachycardia and hypertension associated with preoperative anxiety.
Ketamine was generally well tolerated by patients receiving clonidine. Most patients reported a positive experience and the incidence of postoperative psychological phenomena was not increased in those patients receiving clonidine/ketamine compared with those receiving placebo/ketamine (Figure 4) . Although no comparison of psychological phenomena associated with other anaesthetic regimens was made, this at least suggests that clonidine does not interact adversely with ketamine in this regard.
Since the introduction of ketamine into clinical use, many drugs have been used with it in an attempt to ameliorate the undesirable hypertension and tachycardia. Dundee et al. specifically examined promethazine, practolol, phentolamine, practolol/phentolamine, hexamethonium, procainamide, verapamil, and labetalol. 22,23 They found that none of these was reliable in preventing both the tachycardia and the hypertension. Labetalol was most promising, being very effective in controlling the chronotropic action of ketamine but was inconsistent in controlling the increase in blood pressure.
Benzodiazepines, including diazepam and midazolam, have recently been employed to attenuate some of the hyperdynamic effects of ketamine but the results have been variable. Tuman et al. 24 compared diazepamketamine anaesthesia with high-dose fentanyl in patients premedicated with diazepam, who underwent cardiac surgery. They found the haemodynamic changes associated with induction, intubation, and sternotomy to be comparable with those associated with high-dose fentanyl. On the other hand, Marlow et al. 25 reported a high incidence (25%) of adverse haemodynamic response to intubation in patients undergoing cardiac surgery, who had received midazolam-ketamine to induce anaesthesia. Ramsubramanian et al., 26 in a group of healthy young women, found iv midazolam in doses up to 0.125 mg. kg -I prior to induction to be unreliable in preventing increases in heart rate or blood pressure.
Recently, Munro et al. is used premedication with oral diazepam and clonidine and demonstrated attenuation of the increases in blood pressure, heart rate and rate pressure product associated with induction of anaesthesia with iv ketamine (2 mg. kg-J). Although they administered a fixed dose of clonidine (0.3 mg) with diazepam (10 mg), our results are comparable.
In conclusion, premedication of healthy patients with oral clonidine effectively attenuates but does not eliminate the hyperdynamic response associated with induction of anaesthesia with ketamine. The combination of clonidine and ketamine appears to be well tolerated and is not associated with a greater incidence of psychological phenomena than ketamine alone. It is possible that newer, more potent alpha2 adrenergic agonists under development may be more effective in completely antagonizing these undesirable haemodynamic effects.
